ev3 Inc. - Product Pipeline Analysis by GlobalData

VIEWS: 104 PAGES: 48

More Info
									                                                      ev3 Inc. - Product Pipeline Analysis
     Reference Code: GDME2439PD                                                                                                 Publication Date: NOV 2010



     Company Snapshot                                                       Company Overview
     Key Information
                                                                            ev3 Inc. (ev3) is a global medical device company engaged in developing
      ev3 Inc., Key Facts                                                   innovative technologies and solutions for the endovascular treatment of
                                                                            peripheral vascular and neurovascular diseases. The company principally
      Web Address                            www.ev3.net
                                                                            operates in the US, Canada, Europe and other countries. It offers a wide
      Turnover (in USD Million) 449.10                                      range of treatment options, including primary interventional technologies such
                                                                            as plaque excision systems, stents, peripheral angioplasty balloons, liquid
      Number of Employees                    1,250                          embolics, embolic protection devices, embolization coils, thrombectomy
      Industry                               Pharmaceuticals and            catheters, flow diversion and occlusion balloons. It is headquartered in
                                             Healthcare-                    Minnesota, the US.
      Source:Primary / Secondary Research
      GlobalData



     ev3 Inc. Pipeline Products

      ev3 Inc. Key Pipeline Products by Equipment Type                      ev3 Inc. Key Pipeline Products by Therapy Area

     Equipment Type                                        No of Products   Therapy Area                                                  No of Products
     Peripheral Vascular Devices                                   4        Peripheral artery disease                                        2
     Interventional Neurology                                      3        Acute ischemic stroke                                            1
     Interventional Cardiology                                     1        Aneurysm, Arteriovenous malformation                             1
                                                                            Aneurysm, Intracranial atherosclerotic disease,                  1
                                                                            Thromboembolism
                                                                            Atrial fibrillation                                              1
                                                                            Femoropopliteal occlusive disease                                1
                                                                            Intracranial aneurysm                                            1
      Source: Primary / Secondary Research
                                                                            Source: Primary / Secondary Research
      GlobalData
                                                                            GlobalData


     ev3 Inc. Key Pipeline Products by Equipment Type




      Source: Primary / Secondary Research
      GlobalData




      ev3 Inc. Key Pipeline Products by Development Stage                   ev3 Inc. Key Pipeline Products by Trial Phase

     Developmental Stage                                   No of Products   Trial Phase                                                   No of Products
     Clinicals                                              6               Phase IV                                                 1
     Pre-Clinicals                                          -               Phase III                                                2
     Early development                                                      Phase II                                                 3
                                                            -
     No Specific Phase                                      1               Phase I                                                  2
      Source: Primary / Secondary Research                                  Source: Primary / Secondary Research
      GlobalData                                                            GlobalData
      Note : (-) indicates 'Not Available'




ev3 Inc. - Product Pipeline Analysis                                                                                                 Reference Code: GDME2439PD

Source : www.globalcompanyintelligence.com                                                                                                                   Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 4
     List of Figures......................................................................................................................................................................................................................................................................... 5
     ev3 Inc. - Business Description.............................................................................................................................................................................................................................................. 6
     Key Facts ............................................................................................................................................................................................................................................................................... 7
     ev3 Inc. - Major Products and Services ................................................................................................................................................................................................................................. 8
           ev3 Inc. Pipeline Products by Equipment Type ............................................................................................................................................................................................................. 10
           ev3 Inc. Pipeline Products by Development Stage........................................................................................................................................................................................................ 12
           ev3 Inc. Pipeline Products by Therapy Area.................................................................................................................................................................................................................. 14
           ev3 Inc. Pipeline Products by Trial Phase ..................................................................................................................................................................................................................... 16
           ev3 Inc. Pipeline Products by Milestone Summary ....................................................................................................................................................................................................... 18
           APOLLO Delivery Catheter............................................................................................................................................................................................................................................ 20
                 Product Status......................................................................................................................................................................................................................................................... 20
                 Product Description ................................................................................................................................................................................................................................................. 20
           Next generation plaque excision system ....................................................................................................................................................................................................................... 20
                 Product Status......................................................................................................................................................................................................................................................... 20
                 Product Description ................................................................................................................................................................................................................................................. 20
           Pipeline Embolization Device ........................................................................................................................................................................................................................................ 21
                 Product Status......................................................................................................................................................................................................................................................... 21
                 Product Description ................................................................................................................................................................................................................................................. 21
                 Product Milestone ................................................................................................................................................................................................................................................... 21
                 Pipeline Embolization Device Clinical Trial ............................................................................................................................................................................................................. 21
                 Product Patent Details ............................................................................................................................................................................................................................................ 24
           PLAATO system ............................................................................................................................................................................................................................................................ 25
                 Product Status......................................................................................................................................................................................................................................................... 25
                 Product Description ................................................................................................................................................................................................................................................. 25
                 PLAATO system Clinical Trial ................................................................................................................................................................................................................................. 26
           PROTEGE EverFlex peripheral Stent............................................................................................................................................................................................................................ 27
                 Product Status......................................................................................................................................................................................................................................................... 27
                 Product Description ................................................................................................................................................................................................................................................. 27
                 Product Milestone ................................................................................................................................................................................................................................................... 27
                 PROTEGE EverFlex peripheral Stent Clinical Trial ................................................................................................................................................................................................ 28
                 Product Patent Details ............................................................................................................................................................................................................................................ 30
           RockHawk with SpiderFX Embolic Protection device.................................................................................................................................................................................................... 30
                 Product Status......................................................................................................................................................................................................................................................... 30
                 Product Description ................................................................................................................................................................................................................................................. 31
                 RockHawk with SpiderFX Embolic Protection device Clinical Trial......................................................................................................................................................................... 31
           Solitaire FR Revascularization Device........................................................................................................................................................................................................................... 33
                 Product Status......................................................................................................................................................................................................................................................... 33
                 Product Description ................................................................................................................................................................................................................................................. 33
                 Product Milestone ................................................................................................................................................................................................................................................... 33
                 Solitaire FR Revascularization Device Clinical Trial ............................................................................................................................................................................................... 33
           Solitaire Stent ................................................................................................................................................................................................................................................................ 35
                 Product Status......................................................................................................................................................................................................................................................... 36
                 Product Description ................................................................................................................................................................................................................................................. 36
                 Solitaire Stent Clinical Trial ..................................................................................................................................................................................................................................... 36
           TurboHawk below the knee ........................................................................................................................................................................................................................................... 36
                 Product Status......................................................................................................................................................................................................................................................... 36
                 Product Description ................................................................................................................................................................................................................................................. 37
     ev3 Inc. - Key Competitors................................................................................................................................................................................................................................................... 38
     ev3 Inc. - Key Employees .................................................................................................................................................................................................................................................... 39
     ev3 Inc. - Key Employee Biographies .................................................................................................................................................................................................................................. 40
     ev3 Inc. - Locations And Subsidiaries .................................................................................................................................................................................................................................. 41
           Head Office.................................................................................................................................................................................................................................................................... 41
           Other Locations & Subsidiaries ..................................................................................................................................................................................................................................... 41
     Recent Developments.......................................................................................................................................................................................................................................................... 43
                 Jul 06, 2010: ev3 Agrees To Settle Stockholder Litigation...................................................................................................................................................................................... 43
                 Jun 11, 2010: Ev3 To Expand Peripheral Vascular Manufacturing Facility In Minnesota....................................................................................................................................... 43
                 Jun 01, 2010: Finkelstein Thompson LLP Announces Investigation Of ev3 ........................................................................................................................................................... 43
                 Apr 29, 2010: ev3 Reports Net Income Of $9.8 Million In Q1 2010 ........................................................................................................................................................................ 43

ev3 Inc. - Product Pipeline Analysis                                                                                                                                                                                                                   Reference Code: GDME2439PD

Source : www.globalcompanyintelligence.com                                                                                                                             
								
To top